Artificial intelligence has moved from pilot projects to a central role in many life sciences strategies. What began as a set ...
This figure illustrates three key applications of AI in antimicrobial drug development: (1) target identification and validation, including novel target discovery, affinity prediction, multi-target ...
Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
How innovative technologies like AI and gene editing are advancing rare disease drug discovery and development.
Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...
Pharmaceutical Technology on MSN
RNA-targeting small molecules: a new frontier of drug discovery
With big pharma signalling interest in novel RNA-targeted approaches, the term “druggable” is being redefined as technology advances.
Explore the role of BD&L in R&D decision-making. Understand its impact on funding and market intelligence for scientists.
Zhongyao Ma, PhD, holds a bachelor’s degree in biology from Shanghai Jiao Tong University and a PhD in genetics and developmental biology from the University of Georgia, U.S. His research focused on ...
This new article publication from Acta Pharmaceutica Sinica B, discusses how neg-entropy is the true drug target for chronic diseases. Molecular mechanisms of chronic diseases are complicated, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results